Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (3)
  • 2023 (2)
  • 2021 (3)
  • 2020 (1)

Subject

  • Pharmaceuticals/Pharmacists/Physicians (4)
  • Prescription Drugs (4)
  • Diversion Division (2)
  • Drug Trafficking (1)
  • Fake Pills (1)
  • Guilty Plea (1)
  • OCDETF/Task Force (1)
  • Outreach/Drug Prevention (1)
  • Seizures (Drugs/Property) (1)
  • Task Forces/Task Force Officers (1)

Drug Name

  • Methamphetamine (229)
  • Fentanyl (164)
  • Cocaine (130)
  • Heroin (93)
  • Marijuana (Cannabis) (44)
  • Oxycodone (19)
  • Ecstasy/MDMA (6)
  • LSD (4)
  • Ketamine (3)
  • Marijuana Concentrates (3)
  • Synthetic Opioids (3)
  • Amphetamines (2)
  • Benzodiazepines (1)
  • K2/Spice (1)
  • Steroids (1)
  • Opioids (10)

Field Division

  • Washington, DC (55)
  • Miami (9)
  • Seattle (8)
  • Atlanta (7)
  • Dallas (5)
  • New England (5)
  • Sede (5)
  • Chicago (4)
  • New York (3)
  • St. Louis (3)
  • New Jersey (2)
  • Detroit (1)
  • Rocky Mountain (1)
  • San Diego (1)
  • San Francisco (6)
  • Houston (4)
Clear All Results
PRESS RELEASE

Stockton Man Sentenced to 16 Years and 8 Months in Prison for Fentanyl and Meth Pill Manufacturing and Distribution

Mayo 12, 2025
SACRAMENTO, Calif. —Jamar Deontae Barnes, 43, of Stockton, was sentenced today by U.S. District Judge Dale A. Drozd to 16 years and eight months in prison for conspiracy to manufacture and distribute pills laced with fentanyl, methamphetamine, and other drugs, and possession with intent to distribute methamphetamine-laced pills, Acting U.S...
Mayo 12, 2025
PRESS RELEASE

Madera Pharmacist Sentenced to over 7 Years in Prison for Illegally Trafficking Hundreds of Thousands of Opiate Pills

Noviembre 25, 2024
FRESNO, Calif. — Ifeanyi Vincent Ntukogu, 49, of Fresno, was sentenced today to seven years and three months in prison for illegally distributing oxycodone and hydrocodone. Ntukogu was a pharmacist in Madera who dispensed more than 450,000 oxycodone and hydrocodone pills based on fraudulent prescriptions, all in exchange for cash...
Noviembre 25, 2024
PRESS RELEASE

Multiple Pharmaceutical Distributor Executives, Sales Representatives and Brokers Charged in Connection with Unlawful Sales of over 70M Opioid Pills

Octubre 03, 2024
HOUSTON - Charges have been unsealed as part of a larger enforcement action related to the unlawful distribution of nearly 70 million opioid pills and over 30 million doses of other commonly abused prescription drugs to alleged Houston-area pill-mill pharmacies. Three Houston-area pharmacy operators were also charged for their role...
Octubre 03, 2024
PRESS RELEASE

East Bay Doctor Sentenced to Prison for Distributing Opioids Outside the Scope of Medical Practice

Marzo 18, 2024
OAKLAND, Calif. – Parto Karimi, a former Bay Area doctor, has been sentenced to one year and one day in federal prison for distributing powerful opioids outside the scope of medical practice, announced United States Attorney Ismail J. Ramsey and Drug Enforcement Administration (DEA), San Francisco Field Division, Special Agent...
Marzo 18, 2024
PRESS RELEASE

San Jose Doctor Convicted of Twelve Counts of Illegally Prescribing Opioids

Junio 22, 2023
SAN JOSE, Calif. – A federal jury yesterday convicted family medicine physician Donald Siao of twelve counts of distributing the controlled substances Oxycodone and Hydrocodone outside the scope of his usual professional practice and without a legitimate medical purpose, announced United States Attorney Ismail J. Ramsey, Drug Enforcement Administration (DEA)...
Junio 22, 2023
PRESS RELEASE

Former Modesto Doctor Pleads Guilty to Illegally Prescribing Opioids

Mayo 11, 2023
FRESNO, Calif. — Sawtantra Chopra, 76, of Modesto, pleaded guilty Wednesday to three counts of illegally prescribing opioids and other medication, U.S. Attorney Phillip A. Talbert and Drug Enforcement Administration Special Agent in Charge Brian M. Clark announced. According to court documents, Chopra admitted prescribing drugs — including hydrocodone, alprazolam...
Mayo 11, 2023
PRESS RELEASE

Doctor Convicted of Illegally Prescribing Opioids to Patients

Noviembre 19, 2021
SACRAMENTO, Calif. — Physician Edmund Kemprud, 78, of Dublin, was convicted today of 14 counts of illegally prescribing opioids and other controlled substances patients, Acting U.S. Attorney Phillip A. Talbert announced. According to evidence presented at trial, Kemprud was a physician licensed to practice medicine in California and worked in...
Noviembre 19, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

Septiembre 27, 2021
WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
Septiembre 27, 2021
PRESS RELEASE

Over $1.1M in Civil Settlements Reaffirm DOJ’s Commitment to Preventing Opioid Abuse

Febrero 08, 2021
S AN ANTONIO - The United States Attorney’s Office has collected $792,000 in civil penalties as two more civil Controlled Substances Act (CSA) investigations have settled, announced Drug Enforcement Administration (DEA) Special Agent in Charge Steven S. Whipple, Houston Division and U.S. Attorney Gregg N. Sofer. These civil settlements, coupled...
Febrero 08, 2021
PRESS RELEASE

13 Arrested in Connection with an LSD, Fentanyl and Methamphetamine Trafficking and Money Laundering Scheme Occurring in the West Campus Area of the University of Texas at Austin

Diciembre 04, 2020
Federal, state and local authorities have arrested 13 individuals, including current and former University of Texas (UT) students, charged in connection with trafficking LSD, fentanyl and methamphetamine pills to UT students in Austin. That announcement was made today by U.S. Attorney Gregg N. Sofer; Drug Enforcement Administration (DEA) Special Agent...
Diciembre 04, 2020
Showing 1 - 10 of 10 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster